Marina Bacac

7.6k total citations · 1 hit paper
82 papers, 3.1k citations indexed

About

Marina Bacac is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Marina Bacac has authored 82 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 45 papers in Radiology, Nuclear Medicine and Imaging and 35 papers in Immunology. Recurrent topics in Marina Bacac's work include Monoclonal and Polyclonal Antibodies Research (44 papers), CAR-T cell therapy research (39 papers) and Immunotherapy and Immune Responses (15 papers). Marina Bacac is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (44 papers), CAR-T cell therapy research (39 papers) and Immunotherapy and Immune Responses (15 papers). Marina Bacac collaborates with scholars based in Switzerland, Germany and United States. Marina Bacac's co-authors include Ivan Stamenkovic, Christian Klein, Pablo Umaña, Sylvia Herter, Maries van den Broek, Carola H. Ries, Dana Pe’er, Bernhard Reis, Christian Beisel and Daniel Schulz and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Marina Bacac

82 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Immune Atlas of Clear Cell Renal Cell Carcinoma

2017 694 citations Marina Bacac, Carola H. Ries et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Bacac Switzerland	25	1.9k	1.0k	984	540	435	82	3.1k
Thomas M. Cardillo United States	38	2.4k 1.2×	818 0.8×	1.3k 1.3×	2.0k 3.7×	495 1.1×	94	4.1k
Maarten L. Janmaat Netherlands	17	1.3k 0.7×	567 0.5×	1.0k 1.1×	726 1.3×	525 1.2×	28	2.4k
Pamela A. Trail United States	29	1.5k 0.8×	474 0.5×	1.7k 1.8×	1.2k 2.2×	331 0.8×	61	3.7k
Wijnand Helfrich Netherlands	38	1.2k 0.6×	1.4k 1.3×	1.7k 1.7×	998 1.8×	389 0.9×	114	3.7k
Rodney B. Luwor Australia	32	1.5k 0.8×	485 0.5×	2.0k 2.1×	348 0.6×	428 1.0×	95	3.7k
Muralidhar Beeram United States	27	1.7k 0.9×	291 0.3×	1.3k 1.4×	616 1.1×	835 1.9×	89	3.0k
Ralf Brandt United States	18	2.5k 1.3×	526 0.5×	1.9k 1.9×	632 1.2×	1.1k 2.5×	27	4.0k
Mari Iida United States	30	1.3k 0.7×	456 0.4×	1.5k 1.5×	294 0.5×	620 1.4×	62	2.8k
John Sarantopoulos United States	28	1.3k 0.7×	443 0.4×	1.6k 1.6×	188 0.3×	528 1.2×	143	3.2k
Giorgio Valabrega Italy	28	1.8k 1.0×	477 0.5×	946 1.0×	577 1.1×	490 1.1×	115	2.8k

Countries citing papers authored by Marina Bacac

Since Specialization

Citations

This map shows the geographic impact of Marina Bacac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Bacac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Bacac more than expected).

Fields of papers citing papers by Marina Bacac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Bacac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Bacac. The network helps show where Marina Bacac may publish in the future.

Co-authorship network of co-authors of Marina Bacac

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Bacac. A scholar is included among the top collaborators of Marina Bacac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Bacac. Marina Bacac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masullo, Luciano A., et al.. (2025). Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI. Nature Communications. 16(1). 6768–6768. 1 indexed citations

Schlenker, Ramona, Petra Schwalie, Steffen Dettling, et al.. (2024). Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma. Med. 5(7). 759–779.e7. 5 indexed citations

Essig, Katharina, Sylvia Herter, Marina Bacac, et al.. (2023). Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies. Nature Communications. 14(1). 7888–7888. 8 indexed citations

Wang, Victoria, Tait D. Shanafelt, Connie Lesnick, et al.. (2023). Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial. Blood. 143(1). 57–63. 10 indexed citations

Hänel, Gerulf, Koorosh Korfi, Sylvia Herter, et al.. (2023). Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific. Blood. 142(Supplement 1). 2058–2058. 1 indexed citations

Roux, Julien, Steffen Dettling, Sabrina A. Hogan, et al.. (2023). Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. eLife. 12. 10 indexed citations

Morancho, Beatriz, Marta Escorihuela, Irene Chicote, et al.. (2022). The target antigen determines the mechanism of acquired resistance to T cell-based therapies. Cell Reports. 41(3). 111430–111430. 8 indexed citations

Ovacik, Meric, Christian Pohl, Sylvia Herter, et al.. (2021). A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis. The AAPS Journal. 24(1). 7–7. 4 indexed citations

Karlsen, Tine V., Marek Wagner, Olav Tenstad, et al.. (2021). Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid. Pharmaceutics. 13(12). 2105–2105. 5 indexed citations

10.

Stoltzfus, Caleb, Ramya Sivakumar, Leo Kunz, et al.. (2021). Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity. Frontiers in Immunology. 12. 726492–726492. 22 indexed citations

11.

Weinzierl, Tina, Nicolas Frances, Sylvia Herter, et al.. (2020). Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling. Molecular Cancer Therapeutics. 20(2). 357–366. 16 indexed citations

12.

Herter, Sylvia, Laura S. Grosmaire, Christian Frey, et al.. (2018). The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo. The Journal of Immunology. 200(7). 2304–2312. 14 indexed citations

13.

Klein, Christian, Wolfgang Schaefer, Jörg T. Regula, et al.. (2018). Engineering therapeutic bispecific antibodies using CrossMab technology. Methods. 154. 21–31. 99 indexed citations

14.

Lehmann, Steffi, Johannes Sam, Sara Colombetti, et al.. (2016). In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell–Mediated Tumor Killing. Clinical Cancer Research. 22(17). 4417–4427. 53 indexed citations

15.

Wartha, Katharina, Ekkehard Moessner, Ralf J. Hosse, et al.. (2016). XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer. mAbs. 8(4). 811–827. 27 indexed citations

16.

Herter, Sylvia, Laura Morra, Ramona Schlenker, et al.. (2016). A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents. Cancer Immunology Immunotherapy. 66(1). 129–140. 108 indexed citations

17.

Bacac, Marina, Christian Klein, & Pablo Umaña. (2016). CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors. OncoImmunology. 5(8). e1203498–e1203498. 82 indexed citations

18.

Thommen, Daniela S., Jens Schreiner, Philipp Müller, et al.. (2015). Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors. Cancer Immunology Research. 3(12). 1344–1355. 315 indexed citations

19.

Bacac, Marina, Marta Vadori, Gianni Sava, & Sabrina Pacor. (2004). Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells. Cancer Immunology Immunotherapy. 53(12). 1101–1110. 19 indexed citations

20.

Pacor, Sabrina, Sonia Zorzet, Moreno Cocchietto, et al.. (2004). Intratumoral NAMI-A Treatment Triggers Metastasis Reduction, Which Correlates to CD44 Regulation and Tumor Infiltrating Lymphocyte Recruitment. Journal of Pharmacology and Experimental Therapeutics. 310(2). 737–744. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact